FINANCIAL STATEMENTS 107 4 TAXATION CONTINUED The amounts of deferred taxation accounted for in the Group balance sheet, before netting off of balances within countries, comprised the following deferred tax liabilities and assets: 2006 2005 2004 $m $m$m Deferred tax liabilities Property, plant and equipment and intangible assets 1,321 1,042 1,383 Deferred capital gains 99 94106 Interest accruals 10 28 Untaxed reserves 881 492 360 Other 55 52 94 2,356 1,690 1,971 Deferred tax assets Inter-company inventory transfers 853 821 875 Property, plant and equipment and intangible assets 39 119 44 Accrued expenses 323 200 384 Pension and post-retirement benefits 604 461 475 Share schemes 113 82 42 Other 85 12 41 2,017 1,695 1,861 Net deferred tax asset liability 339 5 110 Untaxed reserves relate to taxable profits where the tax liability is deferred to later periods.
Unrecognised deferred tax assets Deferred tax assets of $103m have not been recognised in respect of deductible temporary differences 2005 $87m, 2004 $62m because it is not probable that future taxable profit will be available against which the Group can utilise the benefits therefrom.
5 EARNINGS PER $0.25 ORDINARY SHARE 2006 2005 2004 Profit for the financial year before exceptional items $m 6,043 4,706 3,378 Exceptional items after tax $m 286 Profit for the financial year $m 6,043 4,706 3,664 Earnings per Ordinary Share before exceptional items $3.86 $2.91 $2.01 Earnings per Ordinary Share on exceptional items $0.17 Earnings per Ordinary Share $3.86 $2.91 $2.18 Diluted earnings per Ordinary Share before exceptional items $3.85 $2.91 $2.01 Diluted earnings per Ordinary Share on exceptional items $0.17 Diluted earnings per Ordinary Share $3.85 $2.91 $2.18 Weighted average number of Ordinary Shares in issue for basic earnings millions 1,564 1,617 1,673 Dilutive impact of share options outstanding millions 6 12 Diluted weighted average number of Ordinary Shares in issue millions 1,570 1,618 1,675 There are no options, warrants or rights outstanding in respect of unissued shares except for employee share option schemes.
The number of options outstanding and the weighted average exercise price of these options is shown in Note 25.
The earnings figures used in the calculations above are unchanged for diluted earnings per Ordinary Share.
Earnings per Ordinary Share before exceptional items in 2004 exclude the effect of two items the profit after tax on the sale of an interest in a joint venture of $228m see Note 2 and tax relief of $58m in respect of an agreement with the US tax authority to allow a part of the Zoladex settlement recognised in 2002 as deductible see Note 4.
